scholarly article | Q13442814 |
P356 | DOI | 10.1177/0885328215579422 |
P698 | PubMed publication ID | 25838352 |
P50 | author | Xanthe L Strudwick | Q59698793 |
Allison J. Cowin | Q38800671 | ||
Damian H Adams | Q40192513 | ||
Penny J. Martens | Q40212176 | ||
Laura Poole-Warren | Q40212203 | ||
P2093 | author name string | Kathryn R Penzkover | |
Mai Ly | |||
P2860 | cites work | Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging | Q57185383 |
Mussel-inspired surface chemistry for multifunctional coatings | Q22242278 | ||
Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery. | Q33361831 | ||
Lentiviral-mediated gene transfer of siRNAs for the treatment of Huntington's disease | Q34349879 | ||
Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors | Q34379208 | ||
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight | Q34393539 | ||
RNAi therapeutics: principles, prospects and challenges | Q34621268 | ||
Modified-chitosan/siRNA nanoparticles downregulate cellular CDX2 expression and cross the gastric mucus barrier | Q35187370 | ||
Functionalized, biodegradable hydrogels for control over sustained and localized siRNA delivery to incorporated and surrounding cells | Q36428234 | ||
Polymeric core-shell nanoparticles for therapeutics | Q36478861 | ||
Applications of RNA interference: current state and prospects for siRNA-based strategies in vivo | Q36801057 | ||
Nanotechnology safety concerns revisited | Q36865560 | ||
Targeted delivery of small interfering RNA: approaching effective cancer therapies | Q37100611 | ||
Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment | Q37408773 | ||
Delivery of RNA interference therapeutics using polycation-based nanoparticles | Q37438876 | ||
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery | Q37504038 | ||
Gene silencing in human aortic smooth muscle cells induced by PEI-siRNA complexes released from dip-coated electrospun poly(ethylene terephthalate) grafts | Q37593277 | ||
Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers | Q37962208 | ||
Advances in siRNA delivery to T-cells: potential clinical applications for inflammatory disease, cancer and infection | Q38144256 | ||
RNAse A-like enzymes in serum inhibit the anti-neoplastic activity of siRNA targeting polo-like kinase 1. | Q40160584 | ||
Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). | Q40428170 | ||
DNA-polycation nanospheres as non-viral gene delivery vehicles | Q41008174 | ||
Gender specific effects on the actin-remodelling protein Flightless I and TGF-beta1 contribute to impaired wound healing in aged skin. | Q46810920 | ||
Amphipathic homopolymers for siRNA delivery: probing impact of bifunctional polymer composition on transfection. | Q51740317 | ||
Attenuation of Flightless I, an actin-remodelling protein, improves burn injury repair via modulation of transforming growth factor (TGF)-beta1 and TGF-beta3. | Q54478006 | ||
Attenuation of flightless I improves wound healing and enhances angiogenesis in a murine model of type 1 diabetes. | Q54509212 | ||
P433 | issue | 3 | |
P304 | page(s) | 257-268 | |
P577 | publication date | 2015-04-02 | |
P1433 | published in | Journal of Biomaterials Applications | Q6294848 |
P1476 | title | In vivo delivery of functional Flightless I siRNA using layer-by-layer polymer surface modification | |
P478 | volume | 30 |
Search more.